Healthy adults
Conditions
Interventions
Participants are to take, without chewing, four tablets of the research food after breakfast once a day for four weeks.
Sponsors
IMEQRD Co. Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age: 20 to less than 65 years 2.Japanese males and females 3.Individuals with a BMI of less than 30.0kg/m^2 4.Capable of entering data via a smartphone or PC electronic diary 5.Individuals who have received adequate explanation regarding the trial, can comprehend its contents, and have produced written consent
Exclusion criteria
Exclusion criteria: 1.Currently undergoing pharmacological treatment (except for on-demand medicines) 2.Currently under dietary or exercise therapy supervised by a physician 3.Individuals with a current or past history of serious disease 4.Those aware of their propensity to develop diarrhea 5.Individuals with surgical history on the digestive tract (appendicitis is acceptable) 6.Individuals with current or past food or drug allergies 7.Habitual heavy drinkers (benchmark: daily pure alcohol consumption exceeding 40g) 8.Heavy smokers (benchmark: over 21 cigarettes per day) 9.Individuals who work night shifts in rotating shifts 10.Those planning major lifestyle changes (diet, sleep, exercise habits, etc.) during the test period, such as long trips 11.Currently pregnant or breastfeeding individuals, or those hoping to get pregnant during the trial period 12.Past occurrences of vasovagal reaction or felt unwell immediately after blood collection 13.Participants in other clinical trials of drugs or health foods, within four weeks post-trial, or planning to participate in other clinical trials after consent to participate in this trial 14.Those who performed blood donation or plasma donation within three months before the start of the trial 15.Individuals deemed unsuitable for the trial by the principal investigator or co-principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -Physical examination (weight, BMI, blood pressure, pulse) -Blood test items (hematological examination, biochemical blood test) -Urinalysis -Incidence of adverse events and side effects | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd. Planning and Sales Department
Outcome results
None listed